Devices › Prosthesis, ankle, semi-constrained, cemented, metal/polymer
Device brand name · Prosthesis ankle semi-constrained cemented metal/polymer
Unknown Total Ankle System: medical device reports filed with FDA
354 reports name it, 2023–2026. Manufacturer given most often on reports: Wright Medical Technology. Product code HSN.
- 354
- device reports naming the brand
- 0% of all MAUDE reports · about 104 a year
- 88
- reports, 12 months to August 2026
- 190 in the 12 months before
- 0%
- classified as malfunction
- 3.4% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
354 medical device reports received by FDA name the brand "Unknown Total Ankle System" (prosthesis ankle semi-constrained cemented metal/polymer); the manufacturer given most often on reports is Wright Medical Technology; received from February 2023 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
88 reports arrived in the 12 months to August 2026, down 54% from 190 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all prosthesis, ankle, semi-constrained, cemented, metal/polymer reports (product code HSN) death is recorded in 0% and malfunction in 3.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (75.4%), osseointegration problem (10.7%) and migration (3.7%). The patient problems coded most often are inadequate osseointegration, cyst(s) and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 7,103 reports carrying product code HSN. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 267 | 75.4% | 21.6% |
| Osseointegration problem | 38 | 10.7% | 16.8% |
| Migrationthe device moved from where it was placed | 13 | 3.7% | 7.9% |
| Unintended movement | 3 | 0.8% | 0.4% |
| Breakthe device broke | 2 | 0.6% | 1.7% |
| Fracturea broken bone | 2 | 0.6% | 2.4% |
| Collapse | 1 | 0.3% | 0.1% |
| Device dislodged or dislocated | 1 | 0.3% | 0.9% |
| Implant subsidence | 1 | 0.3% | 2.1% |
| Inadequacy of device shape and/or size | 1 | 0.3% | 0.7% |
| Loosening of implant not related to bone-ingrowth | 1 | 0.3% | 1.4% |
| Positioning failure | 1 | 0.3% | 0.4% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Inadequate osseointegration | 37 | 10.5% |
| Cyst(s) | 28 | 7.9% |
| Painpain, site not specified | 10 | 2.8% |
| Implant pain | 8 | 2.3% |
| Loss of range of motion | 5 | 1.4% |
| Limb fracture | 3 | 0.8% |
| Osteolysis | 2 | 0.6% |
| Swelling/ edema | 2 | 0.6% |
| Bacterial infectiona bacterial infection | 1 | 0.3% |
| Discomfortdiscomfort | 1 | 0.3% |
| Drug resistant bacterial infection | 1 | 0.3% |
| Failure of implant | 1 | 0.3% |
| Joint impingement | 1 | 0.3% |
| Malunion of bone | 1 | 0.3% |
| Post operative wound infection | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Unknown Total Ankle System | Product code HSN | All MAUDE reports |
|---|---|---|---|
| Reports | 354 | 7,103 | 26,136,888 |
| Share of that pool | — | 5% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 100% | 96.4% | 36.2% |
| Classified as malfunction | 0% | 3.4% | 62.3% |
| Filed by the manufacturer | 100% | 99.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code HSN
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Infinity Total Ankle System | 401 | 0 | 0% |
| Unknown Talar component | 528 | 149 | 1.1% |
| Unknown Tibial Component | 832 | 200 | 0% |
| Unknown Total Ankle Replacement | 185 | 161 | 0% |
| Inbone Total Ankle System | 150 | 0 | 0% |
| Star Total Ankle Replacement | 242 | 0 | 0% |
| Unknown Star Talar Component | 212 | 0 | 0% |
| Unknown Bearing | 317 | 84 | 0.3% |
| Infinity | 193 | 24 | 2.1% |
| Quantum | 183 | 35 | 0.5% |
| Unknown Tibial Tray | 405 | 25 | 0.2% |
| Unknown Depuy Tibial Insert | 728 | 0 | 0% |
| Dow Corning | 297 | 0 | 0.7% |
| Jgrknt 1 0mm Mini 3-0 Ndls | 218 | 3 | 0% |
| UNK Attune Knee Patella | 239 | 23 | 0.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Unknown Total Ankle System reports
How many FDA reports name Unknown Total Ankle System?
354 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 88 in the latest 12 months.
What kinds of events are reported?
injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (75.4%), osseointegration problem (10.7%), migration (3.7%), unintended movement (0.8%) and break (0.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Unknown Total Ankle System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.